S&P 500 7,323.63 −0.23%
Nasdaq 24,429.89 +0.42%
S&P/TSX 34,578.05 −2.09%
Apple 352.45 +0.15%
Nvidia 150.96 −2.89%
Microsoft 508.29 +0.40%
Shopify 199.78 −1.50%
Royal Bank 272.26 −3.11%
CAD/USD 0.6994 +0.01%
PRE-MKT · 05:45 ET
Market ClerkRecap
Thu Nov 19 · pre-market7 signals on Nov 18520 insider buys this week · $248.1MCIRO short report next: Nov 30The week ahead
CT
INSIDER · RPRX · Royalty Pharma plc · EVP & CFO

Coyne Terrance P.

Every open-market transaction filed under this name, Nov 16 to Nov 17.

Filings
5
0 buys · 5 sells
Bought
—
open market, at cost
Sold
$17.7M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Nov 17RPRXRoyalty Pharma plcEVP & CFOSell9,835$68.30$672K+0.5%
Nov 17RPRXRoyalty Pharma plcEVP & CFOSell14,751$68.30$1M+0.5%
Nov 16RPRXRoyalty Pharma plcEVP & CFOSell7,122$68.87$490K−0.3%
Nov 16RPRXRoyalty Pharma plcEVP & CFOSell90,165$68.87$6.2M−0.3%
Nov 16RPRXRoyalty Pharma plcEVP & CFOSell135,249$68.87$9.3M−0.3%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.